This site use cookies for access statistics purposes. Click here for details about cookies policy. Closing this banner you accept the use of these cookies. Close and accept cookies





Myeloid malignancies

We offer sequencing of a panel genes developed by Illumina in collaboration with a consortium of recognized experts in blood cancer.
It enriches, through amplicon-based method, genes frequently mutated in myeloid malignancies:
ABL1, ASXL1, ATRX, BCOR, BCORL1, BRAF, CALR, CBL, CBLB, CBLC, CDKN2A, CEBPA, CSF3R, CUX1, DNMT3A, ETV6/TEL, EZH2, FBXW7, FLT3, GATA1, GATA2, GNAS, HRAS, IDH1, IDH2, IKZF1, JAK2, JAK3, KDM6A, KIT, KRAS, MLL, MPL, MYD88, NOTCH1, NPM1, NRAS, PDGFRA, PHF6, PTEN, PTPN11, RAD21, RUNX1, SETBP1, SF3B1, SMC1A, SMC3, SRSF2, STAG2, TET2, TP53, U2AF1, WT1, ZRSR2

If you would like to add few genes to this enrichment panel, just ask us.
We will be happy to satisfy your needs and support you.
For further information please fill out the form or write to info@galseq.com.